FDA Clears Third Wave's CF Genotyping Test | GenomeWeb
NEW YORK (GenomeWeb News) - Third Wave Technologies today said that the US Food and Drug Administration has cleared its InPlex cystic fibrosis genotyping test.
 
The InPlex CF Molecular Test is based on Third Wave's Invader chemistry and a microfluidic card developed in collaboration with 3M.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.